Heart Stock Based Compensation from 2010 to 2024

HSCS Stock  USD 3.81  0.04  1.06%   
Heart Test Stock Based Compensation yearly trend continues to be comparatively stable with very little volatility. Stock Based Compensation is likely to outpace its year average in 2024. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals
 
Stock Based Compensation  
First Reported
2010-12-31
Previous Quarter
405 K
Current Value
425.3 K
Quarterly Volatility
110.2 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Heart Test financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Heart Test's main balance sheet or income statement drivers, such as Depreciation And Amortization of 58.5 K, Interest Expense of 242.9 K or Selling General Administrative of 2.5 M, as well as many indicators such as Price To Sales Ratio of 349, Dividend Yield of 0.0 or PTB Ratio of 0.42. Heart financial statements analysis is a perfect complement when working with Heart Test Valuation or Volatility modules.
  
Check out the analysis of Heart Test Correlation against competitors.

Latest Heart Test's Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of Heart Test Laboratories over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Heart Test's Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Heart Test's overall financial position and show how it may be relating to other accounts over time.
Stock Based Compensation10 Years Trend
Slightly volatile
   Stock Based Compensation   
       Timeline  

Heart Stock Based Compensation Regression Statistics

Arithmetic Mean168,157
Geometric Mean139,400
Coefficient Of Variation65.56
Mean Deviation76,552
Median135,067
Standard Deviation110,237
Sample Variance12.2B
Range400.6K
R-Value0.52
Mean Square Error9.5B
R-Squared0.28
Significance0.04
Slope12,927
Total Sum of Squares170.1B

Heart Stock Based Compensation History

2024425.3 K
2023405 K
2022248.3 K
202168.4 K
202024.7 K

Other Fundumenentals of Heart Test Laboratories

Heart Test Stock Based Compensation component correlations

0.850.120.68-0.83-0.930.37-0.070.990.180.990.221.0-0.450.960.19-0.430.460.94-0.94
0.850.620.25-1.0-0.65-0.09-0.580.9-0.360.9-0.30.83-0.430.95-0.33-0.420.70.81-0.81
0.120.62-0.45-0.640.09-0.6-0.990.25-0.920.21-0.890.080.010.35-0.90.020.710.11-0.11
0.680.25-0.45-0.27-0.880.850.480.630.670.580.670.710.080.50.620.090.220.64-0.53
-0.83-1.0-0.64-0.270.650.070.61-0.90.39-0.880.32-0.810.36-0.940.360.35-0.76-0.80.78
-0.93-0.650.09-0.880.65-0.66-0.14-0.91-0.42-0.87-0.42-0.940.15-0.83-0.380.13-0.38-0.810.85
0.37-0.09-0.60.850.07-0.660.580.30.810.230.830.40.310.130.80.32-0.10.22-0.32
-0.07-0.58-0.990.480.61-0.140.58-0.20.92-0.160.84-0.04-0.02-0.290.85-0.02-0.68-0.070.07
0.990.90.250.63-0.9-0.910.3-0.20.050.990.090.98-0.390.980.06-0.370.560.92-0.93
0.18-0.36-0.920.670.39-0.420.810.920.050.070.940.210.0-0.070.950.0-0.580.08-0.21
0.990.90.210.58-0.88-0.870.23-0.160.990.070.110.98-0.520.990.08-0.510.480.94-0.95
0.22-0.3-0.890.670.32-0.420.830.840.090.940.110.25-0.09-0.041.0-0.08-0.490.17-0.22
1.00.830.080.71-0.81-0.940.4-0.040.980.210.980.25-0.440.950.22-0.420.440.93-0.94
-0.45-0.430.010.080.360.150.31-0.02-0.390.0-0.52-0.09-0.44-0.47-0.111.00.15-0.530.53
0.960.950.350.5-0.94-0.830.13-0.290.98-0.070.99-0.040.95-0.47-0.07-0.450.580.91-0.92
0.19-0.33-0.90.620.36-0.380.80.850.060.950.081.00.22-0.11-0.07-0.11-0.550.13-0.21
-0.43-0.420.020.090.350.130.32-0.02-0.370.0-0.51-0.08-0.421.0-0.45-0.110.16-0.510.51
0.460.70.710.22-0.76-0.38-0.1-0.680.56-0.580.48-0.490.440.150.58-0.550.160.55-0.25
0.940.810.110.64-0.8-0.810.22-0.070.920.080.940.170.93-0.530.910.13-0.510.55-0.8
-0.94-0.81-0.11-0.530.780.85-0.320.07-0.93-0.21-0.95-0.22-0.940.53-0.92-0.210.51-0.25-0.8
Click cells to compare fundamentals

About Heart Test Financial Statements

Heart Test shareholders use historical fundamental indicators, such as Stock Based Compensation, to determine how well the company is positioned to perform in the future. Although Heart Test investors may analyze each financial statement separately, they are all interrelated. The changes in Heart Test's assets and liabilities, for example, are also reflected in the revenues and expenses on on Heart Test's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Stock Based Compensation405 K425.3 K
Stock Based Compensation To Revenue 21.78  12.45 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Heart Stock Analysis

When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.